4758|10000|Public
5|$|Keto{{acidosis}} is {{not always}} the result of diabetes. It may also result from alcohol excess and from starvation; in both states the <b>glucose</b> <b>level</b> is normal or low. Metabolic acidosis may occur in people with diabetes for other reasons, such as poisoning with ethylene glycol or paraldehyde.|$|E
5|$|Lumbar {{puncture}} {{is performed}} {{to measure the}} opening pressure, {{as well as to}} obtain cerebrospinal fluid (CSF) to exclude alternative diagnoses. If the opening pressure is increased, CSF may be removed for transient relief (see below). The CSF is examined for abnormal cells, infections, antibody levels, the <b>glucose</b> <b>level,</b> and protein levels. By definition, all of these are within their normal limits in IIH. Occasionally, the CSF pressure measurement may be normal despite very suggestive symptoms. This may be attributable to the fact that CSF pressure may fluctuate {{over the course of the}} normal day. If the suspicion of problems remains high, it may be necessary to perform more long-term monitoring of the ICP by a pressure catheter.|$|E
5|$|In vertebrates, {{the part}} of the brain that plays the {{greatest}} role is the hypothalamus, a small region at the base of the forebrain whose size does not reflect its complexity or the importance of its function. The hypothalamus is a collection of small nuclei, most of which are involved in basic biological functions. Some of these functions relate to arousal or to social interactions such as sexuality, aggression, or maternal behaviors; but many of them relate to homeostasis. Several hypothalamic nuclei receive input from sensors located in the lining of blood vessels, conveying information about temperature, sodium level, <b>glucose</b> <b>level,</b> blood oxygen level, and other parameters. These hypothalamic nuclei send output signals to motor areas that can generate actions to rectify deficiencies. Some of the outputs also go to the pituitary gland, a tiny gland attached to the brain directly underneath the hypothalamus. The pituitary gland secretes hormones into the bloodstream, where they circulate throughout the body and induce changes in cellular activity.|$|E
40|$|Diabetes Mellitus (DM) is a {{syndrome}} in metabolism {{of carbohydrates}} which {{indicated by the}} increased <b>level</b> of blood <b>glucose</b> and also may increase salivary <b>glucose</b> <b>levels.</b> Oral ulcer has been frequently recognized in diabetic patients, which can be due to increased glucose in oral fluids and immune dysfunction. This study aimed to determine the correlation of blood <b>glucose</b> <b>levels</b> and salivary <b>glucose</b> <b>levels</b> with oral ulcer in diabetic patients. Analytic observational study was carried out through the determination of blood <b>glucose</b> <b>levels</b> just by way of strip using a glucometer and salivary <b>glucose</b> <b>levels</b> with the method "GOD-PAP test enzymatic colorimetric". Oral ulcer was determined in presenting ulcer on 30 patients with DM. The results showed r = 0. 228, which is higher salivary <b>glucose</b> <b>levels</b> followed by high <b>levels</b> of blood <b>glucose,</b> and intraoral examination of oral ulcer found in the whole sample and the most location commonly found in buccal mucosa and lingual. It was concluded {{that there is a}} correlation between blood <b>glucose</b> <b>levels</b> and salivary <b>glucose</b> <b>levels,</b> and <b>glucose</b> <b>levels</b> affect the occurrence of oral ulcer in patients with D...|$|R
40|$|Background: Blood <b>glucose</b> <b>levels</b> are {{elevated}} {{during the}} perioperative period {{as a result}} of the neuro-endocrine re sponse to the stress of surgery. In nondiabetic patients, blood <b>glucose</b> <b>levels</b> are not a part of routine preoperative testing nor are they monitored during surgery or in the post anesthesia care unit (PACU). We measured blood <b>glucose</b> <b>levels</b> in nondiabetic patients during the perioperative period to identify how many patients had high <b>glucose</b> <b>levels</b> and what factors were associated with increases in blood <b>glucose</b> <b>levels.</b> Methods: This prospective observational study included two hundred and ninety five nondiabetic patients between the ages of 18 and 80 years, undergoing elective noncardiac surgery. Blood <b>glucose</b> <b>levels</b> were measured preoperatively and at frequent, predetermined intervals during surgery and in the PACU. Patient characteristics, surgical and anesthetic factors, and pain scores in the PACU were recorded, as were postoperative complications. Results: Forty nine percent (49 %) of the patients had maximum intraoperative glu cose levels of 126 mg/dl or higher and fifty three percent (53 %) had maximum postoperative <b>glucose</b> <b>levels</b> of 126 mg/dl or higher. Preoperative <b>glucose</b> <b>levels,</b> family history of diabetes and amount of blood loss were statistically sig nificantly associated with both max-intra-op and max-post-op <b>glucose</b> <b>levels.</b> Additionally, blood administration, sur gery duration and race were significantly associated with max-intra-op <b>glucose</b> <b>levels,</b> while amount of intravenous flu ids and sex were significantly associated with max-post-op <b>glucose</b> <b>levels.</b> Conclusion: A large number of nondiabetic patients in our study had maximum <b>glucose</b> <b>levels</b> > 126 mg/dl in the perioperative period. Certain patient characteristics, as well as surgical/anesthetic factors, were associated with increases in the <b>glucose</b> <b>levels.</b> More studies are indicated to determine which patients may benefit from glucose monitoring in the perioperative period. </p...|$|R
40|$|Objectives: To {{study the}} {{correlation}} between blood <b>glucose</b> <b>levels</b> and salivary <b>glucose</b> <b>levels</b> in type 2 diabetic patients, to study the relationship between salivary <b>glucose</b> <b>levels</b> and oral candidal carriage in type 2 diabetic patients and to determine whether salivary <b>glucose</b> <b>levels</b> {{could be used as}} a noninvasive tool for the measurement of glycemic control in type 2 diabetics. Study Design: The study population consisted of three groups: Group 1 consisted of 30 controlled diabetics and Group 2 consisted of 30 uncontrolled diabetics based on their random nonfasting plasma <b>glucose</b> <b>levels.</b> Group 3 consisted of 30 healthy controls. Two milliliters of peripheral blood was collected for the estimation of random nonfasting plasma <b>glucose</b> <b>levels</b> and glycosylated hemoglobin (HbA 1 c). Unstimulated saliva was collected for the estimation of salivary glucose. Saliva was collected by the oral rinse technique for the estimation of candidal counts. Results: The salivary <b>glucose</b> <b>levels</b> were significantly higher in controlled and uncontrolled diabetics when compared with controls. The salivary candidal carriage was also significantly higher in uncontrolled diabetics when compared with controlled diabetics and nondiabetic controls. The salivary <b>glucose</b> <b>levels</b> showed a significant correlation with blood <b>glucose</b> <b>levels,</b> suggesting that salivary <b>glucose</b> <b>levels</b> can be used as a monitoring tool for predicting glycemic control in diabetic patients. Conclusion: The present study found that estimation of salivary <b>glucose</b> <b>levels</b> can be used as a noninvasive, painless technique for the measurement of diabetic status of a patient in a dental set up. Increased salivary <b>glucose</b> <b>levels</b> leads to increased oral candidal carriage; therefore, oral diagnosticians are advised to screen the diabetic patients for any oral fungal infections and further management...|$|R
25|$|When the <b>glucose</b> <b>level</b> {{comes down}} to the usual {{physiologic}} value, insulin release from the β-cells slows or stops. If the blood <b>glucose</b> <b>level</b> drops lower than this, especially to dangerously low levels, release of hyperglycemic hormones (most prominently glucagon from islet of Langerhans alpha cells) forces release of glucose into the blood from the liver glycogen stores, supplemented by gluconeogenesis if the glycogen stores become depleted. By increasing blood glucose, the hyperglycemic hormones prevent or correct life-threatening hypoglycemia.|$|E
25|$|Evidence of {{impaired}} first-phase insulin release {{can be seen}} in the glucose tolerance test, {{demonstrated by}} a substantially elevated blood <b>glucose</b> <b>level</b> at 30 minutes after the ingestion of a glucose load (75 or 100 g of glucose), followed a slow drop over the next 100 minutes, to remain above 120mg/100 ml after two hours after the start of the test. In a normal person the blood <b>glucose</b> <b>level</b> is corrected (and may even be slightly over-corrected) by the end of the test.|$|E
25|$|The {{artificial}} pancreas is a technology in development {{to help people}} with diabetes automatically control their blood <b>glucose</b> <b>level</b> by providing the substitute endocrine functionality of a healthy pancreas.|$|E
50|$|Glucagon {{increases}} blood <b>glucose</b> <b>levels,</b> and DPP-4 inhibitors reduce glucagon {{and blood}} <b>glucose</b> <b>levels.</b> The mechanism of DPP-4 inhibitors {{is to increase}} incretin levels (GLP-1 and GIP), which inhibit glucagon release, which in turn increases insulin secretion, decreases gastric emptying, and decreases blood <b>glucose</b> <b>levels.</b>|$|R
3000|$|..., {{and blood}} <b>glucose</b> <b>levels,</b> but MRGlu {{increased}} with increasing blood <b>glucose</b> <b>levels</b> (Figure  4). Unlike that in MDA, SUV and K [...]...|$|R
50|$|CSF <b>glucose</b> <b>levels</b> can {{be useful}} in {{distinguishing}} among causes of meningitis as more than 50% of patients with bacterial meningitis have decreased CSF <b>glucose</b> <b>levels</b> while patients with viral meningitis usually have normal CSF <b>glucose</b> <b>levels.</b> Contrary to common belief, decrease in <b>glucose</b> <b>levels</b> during a CNS infection is not caused by an increased glucose consumption by leukocytes and bacteria in the CNS, but is thought {{to be the result of}} altered glucose transport through the blood-brain barrier.|$|R
25|$|But hs-CRP {{is not to}} be used {{alone and}} should be {{combined}} with elevated levels of cholesterol, LDL-C, triglycerides, and <b>glucose</b> <b>level.</b> Smoking, hypertension and diabetes also increase the risk level of cardiovascular disease.|$|E
25|$|Anatomic {{pathology}} {{relates to}} the processing, examination, and diagnosis of surgical specimens by a physician trained in pathological diagnosis. Clinical pathology is the division that processes the test requests more familiar to the general public; such as blood cell counts, coagulation studies, urinalysis, blood <b>glucose</b> <b>level</b> determinations and throat cultures. Its subsections include chemistry, hematology, microbiology, immunology, urinalysis and blood bank.|$|E
25|$|Hunger is {{the result}} of a fall in blood <b>glucose</b> <b>level</b> or depriving cells of the ability to metabolize fatty acids—glucoprivation and lipoprivation, respectively, stimulate eating. Detectors in the brain are only {{sensitive}} to glucoprivation; detectors in the liver are sensitive to both glucoprivation and lipoprivation outside the blood–brain barrier. However, no single set of receptors is solely responsible for the information the brain uses to control eating.|$|E
25|$|In early 2014 Google {{reported}} testing prototypes {{of contact}} lenses that monitor <b>glucose</b> <b>levels</b> and alert users when <b>glucose</b> <b>levels</b> cross certain thresholds.|$|R
50|$|There is no {{pathologic}} {{process that}} directly leads to hyperglycorrhachia (high CSF <b>glucose</b> <b>levels)</b> and therefore, high CSF <b>glucose</b> <b>levels</b> have no specific diagnostic importance.|$|R
40|$|Copyright © 2013 Vasanti Tilak et al. This is an {{open access}} article {{distributed}} under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Background: Blood <b>glucose</b> <b>levels</b> are elevated during the perioperative period {{as a result of}} the neuro-endocrine re-sponse to the stress of surgery. In nondiabetic patients, blood <b>glucose</b> <b>levels</b> are not a part of routine preoperative testing nor are they monitored during surgery or in the post anesthesia care unit (PACU). We measured blood <b>glucose</b> <b>levels</b> in nondiabetic patients during the perioperative period to identify how many patients had high <b>glucose</b> <b>levels</b> and what factors were associated with increases in blood <b>glucose</b> <b>levels.</b> Methods: This prospective observational study included two hundred and ninety five nondiabetic patients between the ages of 18 and 80 years, undergoing elective noncardiac surgery. Blood <b>glucose</b> <b>levels</b> were measured preoperatively and at frequent, predetermined intervals during surgery and in the PACU. Patient characteristics, surgical and anesthetic factors, and pain scores in the PACU were recorded, as were postoperative complications. Results: Forty nine percent (49 %) of the patients had maximum intraoperative glu-cose levels of 126 mg/dl or higher and fifty three percent (53 %) had maximum postoperative <b>glucose</b> <b>levels</b> of 126 mg/dl or higher. Preoperative <b>glucose</b> <b>levels,</b> family history of diabetes and amount of blood loss were statistically sig-nificantly associated with both max-intra-op and max-post-op <b>glucose</b> <b>levels.</b> Additionally, blood administration, sur...|$|R
25|$|A {{positive}} result, in {{the absence}} of unequivocal high blood sugar, should be confirmed by a repeat of any of the above methods on a different day. It is preferable to measure a fasting <b>glucose</b> <b>level</b> because of the ease of measurement and the considerable time commitment of formal glucose tolerance testing, which takes two hours to complete and offers no prognostic advantage over the fasting test. According to the current definition, two fasting glucose measurements above 126mg/dl (7.0mmol/l) is considered diagnostic for diabetes mellitus.|$|E
25|$|The goal of islet {{transplantation}} is {{to infuse}} enough islets {{to control the}} blood <b>glucose</b> <b>level</b> removing the need for insulin injections. For an average-size person (70kg), a typical transplant requires about one million islets, isolated from two donor pancreases. Because good control of blood glucose can slow or prevent the progression of complications associated with diabetes, such as nerve or eye damage, a successful transplant may {{reduce the risk of}} these complications. But a transplant recipient will need to take immunosuppressive drugs that stop the immune system from rejecting the transplanted islets.|$|E
25|$|Insulin is {{produced}} in the pancreas and the Brockmann body (in some fish), and released when any of several stimuli are detected. These stimuli include ingested protein and glucose in the blood produced from digested food. Carbohydrates can be polymers of simple sugars or the simple sugars themselves. If the carbohydrates include glucose, then that glucose will be absorbed into the bloodstream and blood <b>glucose</b> <b>level</b> will begin to rise. In target cells, insulin initiates a signal transduction, which {{has the effect of}} increasing glucose uptake and storage. Finally, insulin is degraded, terminating the response.|$|E
5000|$|Type A1: {{abnormal}} oral glucose {{tolerance test}} (OGTT), but normal blood <b>glucose</b> <b>levels</b> during fasting and two hours after meals; diet modification is sufficient to control <b>glucose</b> <b>levels</b> ...|$|R
30|$|With {{detailed}} {{review of}} medical records we captured several pre-operative {{factors that are}} not available through administrative databases. In bivariate analysis, we found that patients without complications had significantly higher <b>glucose</b> <b>levels</b> than those who developed in-hospital complications. In multivariable analysis, higher <b>glucose</b> <b>levels</b> were associated with lower odds of complications. Our review of past studies {{did not find any}} study in RC patient population that evaluated baseline <b>glucose</b> <b>levels</b> and their effect on surgical outcomes. Considering the retrospective nature of the study, it is impossible to conclude if the low <b>glucose</b> <b>levels</b> are a result of advance cancer stages and derangements in carbohydrate metabolism. We were also unable to fully investigate the perioperative management of patients with low or high <b>glucose</b> <b>levels.</b>|$|R
5000|$|In Gluconeogenesis, FOXO1 gene {{regulates the}} <b>glucose</b> <b>levels</b> {{due to the}} low output of hepatic glucose. [...] In mice, it cuts fasting blood <b>glucose</b> <b>levels</b> by {{inhibiting}} formulation of the gluconeogenic genes.|$|R
25|$|Reabsorption is the {{transport}} of molecules from this ultrafiltrate and into the peritubular capillary. It is accomplished via selective receptors on the luminal cell membrane. Water is 99% reabsorbed in the proximal tubule. Glucose at normal plasma levels is completely reabsorbed in the proximal tubule. The mechanism {{for this is the}} Na+/glucose cotransporter. A plasma level of 350mg/dL will fully saturate {{the transport}}ers and glucose will be lost in the urine. A plasma <b>glucose</b> <b>level</b> of approximately 160 is sufficient to allow glucosuria, which is an important clinical clue to diabetes mellitus.|$|E
25|$|In animals, {{this is a}} rate-controlling step of gluconeogenesis, {{the process}} by which cells {{synthesize}} glucose from metabolic precursors. The blood <b>glucose</b> <b>level</b> is maintained within well-defined limits in part due to precise regulation of PEPCK gene expression. To emphasize the importance of PEPCK in glucose homeostasis, over expression of this enzyme in mice results in symptoms of type II diabetes mellitus, by far {{the most common form of}} diabetes in humans. Due to the importance of blood glucose homeostasis, a number of hormones regulate a set of genes (including PEPCK) in the liver that modulate the rate of glucose synthesis.|$|E
25|$|To a small extent, {{hemoglobin}} A slowly combines with glucose at {{the terminal}} valine (an alpha aminoacid) of each β chain. The resulting molecule {{is often referred}} to as Hb A1c. As the concentration of glucose in the blood increases, the percentage of Hb A that turns into Hb A1c increases. In diabetics whose glucose usually runs high, the percent Hb A1c also runs high. Because of the slow rate of Hb A combination with glucose, the Hb A1c percentage is representative of <b>glucose</b> <b>level</b> in the blood averaged over a longer time (the half-life of red blood cells, which is typically 50–55 days).|$|E
30|$|Mice {{were treated}} with five {{consecutive}} daily doses of STZ dissolved in citrate buffer (55 mg/kg, pH 4.5) via the intraperitoneal route. One week after the first dose, <b>glucose</b> <b>levels</b> were assessed by glucometer. The criteria of two consecutive <b>glucose</b> <b>levels</b> > 250 mg/dL was used to indicate diabetes. If <b>glucose</b> <b>levels</b> were < 250 mg/dL, then the mice received two additional doses of STZ (55 mg/kg).|$|R
40|$|Animals {{bearing a}} cachexia-inducing tumour, the MAC 16 adenocarcinoma, showed a {{progressive}} decrease in blood <b>glucose</b> <b>levels</b> with increasing weight loss, while animals bearing a histologically similar tumour, the MAC 13 adenocarcinoma, showed {{no change in}} either body weight or blood <b>glucose</b> <b>levels</b> with growth of the tumour. The effect of the MAC 16 tumour on blood <b>glucose</b> <b>levels</b> appeared to be unrelated to food intake, glucose consumption by the tumour, or {{to the production of}} increased levels of IGF-I and IGF-II mRNA by the tumour cells. The relationship between the induction of cachexia and alteration in blood <b>glucose</b> <b>levels</b> remains unknown...|$|R
40|$|Background: {{uncontrolled}} {{diabetes mellitus}} will to complication of various Complications like stroke, hypertension, and heart disease. Complications {{due to increased}} production of free radical for high blood <b>glucose</b> <b>levels.</b> To keep blood <b>glucose</b> <b>levels</b> to normal, it necessary good consuming vitamins c. Vitamin c is necessary for diabetics mellitus to prevent oxidative and blood <b>glucose</b> <b>levels</b> in lowering triglycerides. objective: to know patterns of consumption vitamin c and <b>glucose</b> <b>levels</b> of triglyceride in the blood as in diabetes mellitus. Method: this study was observational with of cross sectional approach. Data consumption patterns of vitamin c, used food frequency (FFQ laboratories to examination and blood <b>glucose</b> <b>levels</b> and triglycerides. data analysis used spearman rank test. Results: of: intake of vitamin c from food and supplements of vitamin c was enough (98. 6...|$|R
25|$|Periodontitis {{has been}} linked to {{increased}} inflammation in the body, such as indicated by raised levels of C-reactive protein and interleukin-6. It is linked through this to increased risk of stroke, myocardial infarction, and atherosclerosis. It also linked in those over 60 years of age to impairments in delayed memory and calculation abilities. Individuals with impaired fasting glucose and diabetes mellitus have higher degrees of periodontal inflammation, and often have difficulties with balancing their blood <b>glucose</b> <b>level</b> owing to the constant systemic inflammatory state, caused by the periodontal inflammation. Although no causal association was proven, a recent study showed correlation between chronic periodontitis and erectile dysfunction.|$|E
25|$|Roughly, transudates are {{a result}} of {{increased}} pressure in the hepatic portal vein (>8 mmHg, usually around 20 mmHg), e.g. due to cirrhosis, while exudates are actively secreted fluid due to inflammation or malignancy. As a result, exudates are high in protein and lactate dehydrogenase and have a low pH (<7.30), a low <b>glucose</b> <b>level,</b> and more white blood cells. Transudates have low protein (<30 g/L), low LDH, high pH, normal glucose, and fewer than 1 white cell per 1000nbsp&mm³. Clinically, the most useful measure is the difference between ascitic and serum albumin concentrations. A difference of less than 1 g/dl (10 g/L) implies an exudate.|$|E
2500|$|... {{initiation}} {{of a combination}} bolus with the initial spike sized {{in proportion to the}} present blood <b>glucose</b> <b>level</b> and trends in the change of blood <b>glucose</b> <b>level,</b> ...|$|E
40|$|To access publisher's {{full text}} {{version of this}} article click on the {{hyperlink}} belowSequence variants that affect mean fasting <b>glucose</b> <b>levels</b> do not necessarily affect risk for type 2 diabetes (T 2 D). We assessed the effects of 36 reported glucose-associated sequence variants on between- and within-subject variance in fasting <b>glucose</b> <b>levels</b> in 69, 142 Icelanders. The variant in TCF 7 L 2 that increases fasting <b>glucose</b> <b>levels</b> increases between-subject variance (5. 7 % per allele, P = 4. 2 × 10 (- 10)), whereas variants in GCK and G 6 PC 2 that increase fasting <b>glucose</b> <b>levels</b> decrease between-subject variance (7. 5 % per allele, P = 4. 9 × 10 (- 11) and 7. 3 % per allele, P = 7. 5 × 10 (- 18), respectively). Variants that increase mean and between-subject variance in fasting <b>glucose</b> <b>levels</b> tend to increase T 2 D risk, whereas those that increase the mean but reduce variance do not (r(2) = 0. 61). The variants that increase between-subject variance increase fasting glucose heritability estimates. Intuitively, our results show that increasing the mean and variance of <b>glucose</b> <b>levels</b> is more likely to cause pathologically high <b>glucose</b> <b>levels</b> than increase in the mean offset by a decrease in variance...|$|R
50|$|Results {{are often}} ready in 1 to 2 hours. <b>Glucose</b> <b>levels</b> in {{a blood sample}} taken from the vein (called a blood plasma value) may differ a little from <b>glucose</b> <b>levels</b> checked with a finger stick.|$|R
50|$|GLUT1 is {{responsible}} for the low <b>level</b> of basal <b>glucose</b> uptake required to sustain respiration in all cells. Expression levels of GLUT1 in cell membranes are increased by reduced <b>glucose</b> <b>levels</b> and decreased by increased <b>glucose</b> <b>levels.</b>|$|R
